Why almost 80% of my patients are quietly quitting Ozempic

Historical Context of Weight Loss Solutions00:00:32

The video reviews past weight loss fads, such as 1960s amphetamines and 1990s fen-phen, noting that they all followed a similar trajectory of initial hype followed by discontinuation due to severe side effects or ineffectiveness.

Low Long-Term Adherence00:03:20

Data shows that approximately 60% to 80% of patients discontinue GLP-1 drugs within one to two years. The speaker argues that this is not due to a lack of understanding but rather a conscious choice to prioritize quality of life.

The 'Beige' Life Effect00:06:54

Ozempic functions by suppressing appetite and the pleasure centers associated with eating. Patients often report that losing the joy of food and social dining experiences makes life feel 'beige,' leading many to stop the medication.

Plateaus and Diminishing Returns00:10:17

A major clinical challenge is that weight loss typically plateaus after 6 to 9 months. Once the weight loss stops, patients are left with the burden of side effects and reduced pleasure in food, without the ongoing reward of visible progress.

Conclusion and Patient Decision Making00:12:42

The speaker concludes that while the drugs have biological benefits, the long-term trade-offs—side effects, loss of enjoyment in life, and plateauing results—often outweigh the benefits for the majority of patients.